Fangzhou Inc. (6086)
Market Closed
14 Sep, 08:00 AM
HKEX 
XFRA Primary HKEX 0. 70
HKD -0.03
-4.0816%
8.24B Market Cap
- P/E Ratio
- Div Yield
308,000 Volume
- Eps
0.74 HKD
Previous Close Want to track 6086 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
6086 closed Monday lower at 0.7 HKD, a decrease of -4.0816% from Friday's close, completing a monthly decrease of -2.7586% or -0.02 HKD. Over the past 12 months, 6086 stock lost -69.6121%.
6086 is not paying dividends to its shareholders.
The last earnings report, released on Feb 25, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).
6086 Chart
Fangzhou Inc. (6086) FAQ
What is the stock price today?
The current price is 0.70 HKD.
On which exchange is it traded?
Fangzhou Inc. is listed on HKEX.
What is its stock symbol?
The ticker symbol is 6086.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 8.24B.
Has Fangzhou Inc. ever had a stock split?
No, there has never been a stock split.
Fangzhou Inc. Profile
| - Industry | - Sector | Mr. Yuming Zou CEO | HKEX Exchange | KYG3314S1066 ISIN |
| DE Country | 494 Employees | - Last Dividend | - Last Split | - IPO Date |
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases. It also provides H2H services, including online medical consultation services, e-prescription, and prescription refill services through mobile application; and healthcare products through online retail pharmacy service platform; as well as operates hospitals. Fangzhou Inc. has a strategic collaboration with Youcare Pharmaceutical Group Co., Ltd. to accelerate the digital transformation and enhancement of chronic disease services through the application of artificial intelligence. Fangzhou Inc. was founded in 2015 and is based in Guangzhou, China.
Contact Information
Address: Building S, Kehui Jingu, Guangzhou, China
Phone: 86 40 0086 5111
Website: https://Jianke.com
2026 © Marketlog. All Rights Reserved.
